Skip to main content
Ajanta Pharma Ltd. logo

Ajanta Pharma Ltd. — Investor Relations & Filings

Ticker · AJANTPHARM ISIN · INE031B01049 LEI · 3358008XLYJJZBFBCK12 BSE.NS Manufacturing
Filings indexed 769 across all filing types
Latest filing 2026-05-12 Regulatory Filings
Country IN India
Listing BSE.NS AJANTPHARM

About Ajanta Pharma Ltd.

https://www.ajantapharma.com

Ajanta Pharma Ltd. is a specialty pharmaceutical organization engaged in the development, manufacturing, and marketing of high-quality finished dosage formulations. The company maintains a significant presence in specialized therapeutic segments, including ophthalmology, dermatology, cardiology, and pain management. It operates advanced research and development centers dedicated to creating complex generics and first-to-market products. With a global footprint, the firm serves diverse healthcare needs across the United States and various emerging markets in Asia and Africa. Its manufacturing infrastructure comprises multiple state-of-the-art facilities designed to meet international regulatory standards, ensuring the delivery of effective and affordable healthcare solutions. The company's strategic focus remains on niche product categories and branded generics, supported by a robust supply chain and a commitment to innovation in drug delivery systems.

Recent filings

Filing Released Lang Actions
Pls find enclosed submission of Secretarial Compliance Report for the year ended 31.03.2026 pursuant to Reg 24A of LODR.
Regulatory Filings Classification · 85% confidence The document is an Annual Secretarial Compliance Report for the year ended March 31, 2026, prepared by a Practicing Company Secretary under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It consists of detailed compliance tables and statutory references, and is being submitted to stock exchanges. This is a regulatory compliance filing rather than a financial report (10-K, IR) or earnings release. It best fits the “Regulatory Filings” category (RNS) as it is neither a pure announcement of a report (RPA) nor a standalone audit/annual report.
2026-05-12 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-05-08 English
Pls find enclosed Written Transcript of Earnings Call held on 5th May 2026.
Regulatory Filings
2026-05-08 English
Copy of Newspaper Publication
Regulatory Filings
2026-05-06 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2026-05-05 English
General Updates
Regulatory Filings
2026-05-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.